Exchange Auditorium: Selected Free Communications

Mark Sibbering
Professor Ian Ellis
15 Jan 2018
16:25-17:40
Exchange Auditorium
Back

Exchange Auditorium: Selected Free Communications

Chairs: Professor Ian Ellis & Mr Mark Sibbering

16.25 – 16.40
Peri‐operative aromatase inhibitor treatment in determining or predicting long-term outcome in early breast cancer – the POETIC Trial (CRUK/07/015)
Professor Ian Smith, Royal Marsden Hospital, London

16.40 – 16.55
Increasing the dose density of adjuvant chemotherapy by shortening intervals between courses or by sequential drug administration significantly reduces breast cancer recurrence and mortality: an EBCTCG meta-analysis of 34,123 women in 25 randomised trials
Miss Rosie Bradley, University of Oxford

16.55 – 17.10
Integration of clinical variables for the prediction of late distant recurrence in patients with oestrogen receptor positive breast cancer treated with 5 years of endocrine therapy
Dr Ivana Sestak, Centre for Cancer Prevention, Queen Mary University London

17.10 – 17.25
A phase III multicentre double blind randomised trial of celecoxib versus placebo in primary breast cancer patients (REACT – Randomised EuropeAn Celecoxib Trial)
Miss Holly Tovey, Institute of Cancer Research, London

17.25 – 17.40
Impact of a BRCA germline mutation on survival – Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH)
Professor Diana Eccles, University of Southampton